Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday.
TCMD has been the subject of several other reports. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. B. Riley began coverage on shares of Tactile Systems Technology in a research report on Thursday, September 26th. They set a “buy” rating and a $23.00 target price on the stock. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th.
Check Out Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Trading Down 1.2 %
Institutional Investors Weigh In On Tactile Systems Technology
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TCMD. Arcadia Investment Management Corp MI acquired a new stake in shares of Tactile Systems Technology in the third quarter worth approximately $29,000. Gladius Capital Management LP purchased a new position in shares of Tactile Systems Technology in the 3rd quarter worth about $44,000. Quarry LP purchased a new stake in Tactile Systems Technology during the 2nd quarter worth approximately $46,000. SG Americas Securities LLC bought a new stake in shares of Tactile Systems Technology in the 3rd quarter worth approximately $156,000. Finally, Magnetar Financial LLC bought a new stake in Tactile Systems Technology during the second quarter worth approximately $130,000. Institutional investors own 83.43% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
See Also
- Five stocks we like better than Tactile Systems Technology
- Most Volatile Stocks, What Investors Need to Know
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Are Penny Stocks a Good Fit for Your Portfolio?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Health Care Stocks Explained: Why You Might Want to Invest
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.